Novus Biologicals™ CD27 Ligand/TNFSF7/CD70 Antibody (cusatuzumab) - Humanized, Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB465688-Each-of-1 | In Stock | ₹ 15,048.12 |
NB465688 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 15,048.12
GST (18%): ₹ 2,708.662
Total Price: ₹ 17,756.782
Antigen
CD27 Ligand/TNFSF7/CD70
Classification
Monoclonal
Conjugate
Unconjugated
Gene Accession No.
P32970
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Isotype
IgG1
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
cusatuzumab
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
CD27-L, CD27LCD27 ligand, CD27LG, CD70, CD70 molecule, Ki-24 antigen, surface antigen CD70, TNFSF7CD70 antigen, tumor necrosis factor (ligand) superfamily, member 7, Tumor necrosis factor ligand superfamily member 7
Immunogen
TNFSF7/ CD27L/ CD70
Quantity
50 μg
Research Discipline
Apoptosis
Gene ID (Entrez)
970
Target Species
Human
Form
Purified
Related Products
Description
- CD27 Ligand/TNFSF7/CD70 Monoclonal antibody specifically detects CD27 Ligand/TNFSF7/CD70 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay